Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Clindamycin phosphate 1% topical (acne)
A topical antibiotic for acne that is slow rather than weak, and works best paired with a retinoid or benzoyl peroxide. Combined with a retinoid it is the most effective topical option for moderate-to-severe acne.
Prescription medication — not a dietary supplement
Clindamycin (topical) is a prescription (or investigational) drug, not a supplement. It is included here for reference because people research and discuss it (often used off-label) — not as a recommendation. Take it only under a qualified clinician's supervision and only as prescribed; do not source it from grey-market vendors, where identity, purity, and dosing are unverified. The evidence below reflects its clinical trials.
What the evidence says
Clindamycin (topical) doesn't have enough studies with structured effect-size data yet to pool a verdict. Browse the studies below for individual findings.
Most evidence is from high-quality meta-analyses and randomised trials published 2010–2026 with a typical study size of 22,645 participants.
Based on 15 studies · 5 meta-analyses · 2 RCTs · 122,425 total participants
Study base
15 studies indexedBy outcome
Every outcome below: Too few graded studies.
A large, high-quality evidence base, and the score reflects what it shows rather than the volume. In combination it is genuinely first-line: clindamycin with a retinoid was the most effective TOPICAL option for moderate-to-severe acne across 179 randomised trials (44.43%, 95% CrI 29.20-60.02%), and clindamycin with benzoyl peroxide lifted self-reported improvement 35% to 49%. As monotherapy it appears slow rather than weak: lowest of the actives at 2-4 weeks (21.5% vs benzoyl peroxide's 33.4%) and numerically level by 10-12 weeks (45.9% vs 43.7%), on point estimates that were never formally compared. Held below Strong for three reasons: a 2026 network meta-analysis of 22,645 patients could not separate topical antibiotic monotherapy from placebo on lesion counts, benzoyl peroxide plus adapalene (54%) beats benzoyl peroxide plus clindamycin (49%), and documented resistance limits how long it can be used.
9 trials ongoing or recruiting · 53 completed on ClinicalTrials.gov
26 of the completed trials have posted results
Registered trials show research momentum for Clindamycin (topical), not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Nov 2026
Clindamycin 1% is a topical antibiotic for acne, and the evidence on it resolves into one clear rule: use it in combination, not alone.
Paired with a topical retinoid it was the most effective topical option for moderate-to-severe acne in a network meta-analysis of 179 randomised trials (44.43% lesion reduction, 95% CrI 29.20-60.02%). Paired with benzoyl peroxide it lifted self-reported improvement from 35% to 49%.
Alone it is a different picture, and the interesting finding is that it is SLOW rather than weak. At 2 to 4 weeks it reads 21.5% inflammatory lesion reduction against benzoyl peroxide's 33.4%, the lowest of the actives; by 10 to 12 weeks the two read 45.9% against 43.7%.
Neither comparison was formally tested, so treat the pattern as suggestive. A 2026 network meta-analysis of 34 trials and 22,645 patients still could not separate topical antibiotic monotherapy from placebo on lesion counts, though clindamycin did beat placebo on the investigator's global assessment.
Two limits are worth knowing before starting. Benzoyl peroxide plus adapalene (54%) outperforms benzoyl peroxide plus clindamycin (49%), so clindamycin is not even the best partner for benzoyl peroxide.
And for non-inflammatory acne, blackheads and whiteheads, a 2025 network meta-analysis concluded that adding clindamycin is unnecessary and should be avoided. Over all of it sits antibiotic resistance, which is why guidelines pair it with benzoyl peroxide and limit course length.
Clindamycin is a lincosamide. It binds the 50S subunit of the bacterial ribosome and blocks protein synthesis, which suppresses Cutibacterium acnes in the follicle. It is bacteriostatic at the concentrations reached in skin, and that single-target mechanism is exactly what makes resistance easy for the organism to acquire.
Part of the benefit is independent of killing bacteria: topical antibiotics also dampen the inflammatory response in the follicle. That is the usual explanation for why global assessment scores can improve on clindamycin even where lesion counts do not separate from placebo.
Pairing clindamycin with benzoyl peroxide is recommended for two reasons. Benzoyl peroxide adds its own comedolytic and antibacterial action, and because it kills bacteria by oxidation rather than a single protein target, resistance to it is not meaningfully acquired. Combining the two suppresses the emergence of clindamycin-resistant organisms.
The American Academy of Dermatology considers topical clindamycin an acne option in pregnancy after review by your obstetric and dermatology clinicians. Ask them to assess the exact prescription product, its strength, any combined ingredient and how long you will use it. Have the exact topical product reviewed for this pregnancy and follow the agreed treatment plan. Requiring review does not mean topical clindamycin is contraindicated. Breastfeeding needs its own assessment of the product. Do not stop prescribed treatment on your own.
LactMed considers infant adverse effects unlikely from topical acne use. Avoid application where the infant can lick or contact the medicine, including the nipple/breast. Assess combined ingredients separately; do not stop breastfeeding or prescribed therapy automatically.
Acne guidelines address patients aged 9 and older, and topical antibiotic combinations are used in adolescents. A clinician decides the product and the course length.
Resistance data argue against long-term clindamycin monotherapy. If a regimen is clindamycin alone and open-ended, that is worth raising with the prescriber.
Stacking two topical antibiotics adds selective pressure for resistance without evidence of added benefit. The pairing that is recommended is with benzoyl peroxide, which is not an antibiotic.
Systemic clindamycin can enhance neuromuscular blockade. How much reaches the body from topical use depends on the formulation, amount and area treated, and for the topical route this is a theoretical concern rather than a documented one, but the drug class carries the warning.
The available source did not grade how severe these reactions were. This does not mean they were mild.
The available source did not grade how severe these reactions were. This does not mean they were mild.
Clindamycin (topical) has an evidence score of 6.5/10 — moderate evidence based on 15 indexed studies, including 5 meta-analyses. A topical antibiotic for acne that is slow rather than weak, and works best paired with a retinoid or benzoyl peroxide. Combined with a retinoid it is the most effective topical option for moderate-to-severe acne. Representative study: PMID 42105175.
Timing is flexible for Clindamycin (topical) — consistent daily use matters more than the time of day. No time-of-day pharmacology.
Clindamycin (topical) has a safety rating of "moderate". That is a category, not a measure of individual risk, and there are precautions worth knowing. Selected serious risks: antibiotic-associated diarrhoea or colitis. How often they occur is not established for all of them. Reported side effects include dryness, peeling or mild burning at the application site, contact dermatitis. How often they occur is not established for all of them. Use caution if any of these apply to you: Known hypersensitivity to clindamycin or lincomycin; A history of antibiotic-associated colitis.
Adapalene
Too few graded studiesOTC medicineA modern topical retinoid for acne — now available over the counter (0.1%) as well as by prescription (0.3%). A drug, not a supplement or cosmetic. Adapalene is a third-generation retinoid selective for the retinoic-acid receptor beta; it normalizes how skin cells shed (comedolytic) and is anti-inflammatory. The honest framing: this is one of the best-evidenced acne treatments — a 5-trial meta-analysis and a 40-trial network meta-analysis show it matches tretinoin's efficacy with faster onset and notably better tolerability, and the adapalene-benzoyl peroxide combination is among the most effective regimens available. Caveats: it still causes retinoid irritation and slow onset, it is not superior to (only as good as) other retinoids, and — as a retinoid — it is generally avoided in pregnancy.
Benzoyl Peroxide
Too few graded studiesOTC medicineA frontline over-the-counter acne medicine applied to the skin — a drug, not a supplement or cosmetic. Benzoyl peroxide (BPO) kills the acne bacterium Cutibacterium (Propionibacterium) acnes by an oxidative mechanism that, crucially, does NOT drive antibiotic resistance, and it is also mildly comedolytic and anti-inflammatory. The honest framing: this is one of the best-evidenced topical acne treatments — a 120-trial Cochrane review and a 35-RCT network meta-analysis show it beats placebo and matches topical antibiotics — but it commonly causes dryness and irritation, it bleaches fabrics, towels, and hair, and BPO monotherapy is consistently outperformed by fixed combinations (adapalene-BPO, clindamycin-BPO). A genuinely effective acne drug with real, manageable downsides.
Tretinoin (Retin-A)
Too few graded studiesPrescription drugA prescription TOPICAL retinoid (Retin-A, Renova) — the acid form of vitamin A and the gold-standard, best-evidenced topical treatment for photoaging and acne. Multiple double-blind RCTs show it reduces fine wrinkles, mottled hyperpigmentation, and roughness over months, with histologic increases in dermal collagen. Caveats: retinoid dermatitis (irritation, peeling, dryness), photosensitivity, and it is CONTRAINDICATED IN PREGNANCY. Prescription drug, not a supplement; distinct from weaker OTC 'retinol' cosmetics.
Azelaic Acid
Too few graded studiesCosmetic compoundA topical skincare acid applied to the skin for rosacea, acne, and uneven tone — unusual among 'cosmetic' actives because it has genuine drug-grade evidence. Azelaic acid is a naturally occurring dicarboxylic acid that is anti-inflammatory, antimicrobial, and a tyrosinase inhibitor. It is sold both as an over-the-counter cosmetic (around 10%) AND as a 15-20% prescription medication. The honest framing: the strongest, best-replicated evidence — including double-blind phase III trials and a Cochrane review that rated it high-quality for papulopustular rosacea — used the PRESCRIPTION strengths (15-20%), not the ~10% OTC cosmetic form. It also has solid evidence for acne and melasma. Head-to-head it is beaten for acne (by benzoyl peroxide + clindamycin) and tends to cause more local irritation (burning, stinging) than several comparators. For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route.
Explore: Best supplements for Skin, Hair & Beauty
Edited by Dr. Baher Al Hakim · Last updated November 2026 · evidence from 15 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.